POLL: Which September FDA Approval Are You Looking Forward To?

Poll

Click here to answer this week's poll.

Which September FDA Approval Are You Looking Forward To?

Revance's daxibotulinumtoxinA for glabbelar lines; PDUFA September 8, 2022
Bristol Myers Squibb's deucravacitinib for psoriasis; PDUFA September 10, 2022
Sanofi/Regneron's dupilumab for prurigo nodularis; PDUFA September 30, 2022
Related Content

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

POLL: What is an Ideal Initial Treatment for Low-Risk Basal Cell Carcinoma?

September 6th 2023

POLL: What Topical Treatments Do You Find the Most Efficacious in Acne Vulgaris Management?

September 5th 2023

POLL: Do You Diagnose and Treat Psoriasis Through Telehealth Appointments?

September 1st 2023

POLL: What Treatment Approach Do You Find Most Successful for Improving Melasma?

August 28th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

POLL: What is an Ideal Initial Treatment for Low-Risk Basal Cell Carcinoma?

September 6th 2023

POLL: What Topical Treatments Do You Find the Most Efficacious in Acne Vulgaris Management?

September 5th 2023

POLL: Do You Diagnose and Treat Psoriasis Through Telehealth Appointments?

September 1st 2023

POLL: What Treatment Approach Do You Find Most Successful for Improving Melasma?

August 28th 2023

POLL: Are You Attending Maui Derm NP+PA Fall 2023?

September 26th 2023

POLL: What Strategies Have You Found Most Effective in Managing Alopecia?

September 25th 2023

POLL: What is an Ideal Initial Treatment for Low-Risk Basal Cell Carcinoma?

September 6th 2023

POLL: What Topical Treatments Do You Find the Most Efficacious in Acne Vulgaris Management?

September 5th 2023

POLL: Do You Diagnose and Treat Psoriasis Through Telehealth Appointments?

September 1st 2023

POLL: What Treatment Approach Do You Find Most Successful for Improving Melasma?

August 28th 2023
© 2023 MJH Life Sciences

All rights reserved.